Shames Richard S. 4
4 · Protagonist Therapeutics, Inc · Filed Oct 10, 2017
Insider Transaction Report
Form 4
Shame Richard S
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2017-10-05$4.21/sh+2,017$8,492→ 2,017 total - Exercise/Conversion
Stock Option (right to buy)
2017-10-05−2,017→ 36,802 totalExercise: $4.21Exp: 2026-04-29→ Common Stock (2,017 underlying) - Sale
Common Stock
2017-10-05$19.00/sh−2,017$38,323→ 0 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 9, 2017.
- [F2]The option vests over a four-year period, with 1/4th of the shares subject to the option vesting on the one year anniversary of the vesting commencement date, and 1/36th of the remaining shares subject to the option vesting each month, subject to the Reporting Person continuing to be a service provider of the Issuer through each such date.